ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
18.49
-0.46 (-2.43%)
At close: Mar 31, 2025, 4:00 PM
17.71
-0.78 (-4.22%)
Pre-market: Apr 1, 2025, 4:22 AM EDT

ArriVent BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
74.29150.39163.3737.28
Short-Term Investments
144.57---
Cash & Short-Term Investments
218.86150.39163.3737.28
Cash Growth
45.53%-7.95%338.23%-
Other Receivables
0.50.760.50.25
Receivables
0.50.760.50.25
Prepaid Expenses
0.410.370.330.03
Other Current Assets
7.218.4518.425.39
Total Current Assets
226.98159.97182.6242.95
Property, Plant & Equipment
0.150.290.14-
Long-Term Investments
47.68---
Long-Term Deferred Charges
-2.73--
Other Long-Term Assets
0.130.110.070.09
Total Assets
274.94163.1182.8343.04
Accounts Payable
3.784.533.090.29
Accrued Expenses
13.336.955.141.53
Current Portion of Leases
0.160.140.13-
Total Current Liabilities
17.2711.628.361.82
Long-Term Leases
0.010.180.01-
Total Liabilities
17.2911.88.371.82
Common Stock
0---
Additional Paid-In Capital
496.24.653.42.96
Retained Earnings
-238.33-157.85-88.51-51.61
Comprehensive Income & Other
-0.21---0
Total Common Equity
257.65-153.19-85.11-48.64
Shareholders' Equity
257.65151.3174.4641.22
Total Liabilities & Equity
274.94163.1182.8343.04
Total Debt
0.180.320.14-
Net Cash (Debt)
218.69150.07163.2337.28
Net Cash Growth
45.72%-8.06%337.86%-
Net Cash Per Share
6.9570.10127.8252.42
Filing Date Shares Outstanding
34.0233.4931.960.71
Total Common Shares Outstanding
33.712.752.60.71
Working Capital
209.71148.34174.2641.13
Book Value Per Share
7.64-55.80-32.76-68.40
Tangible Book Value
257.65-153.19-85.11-48.64
Tangible Book Value Per Share
7.64-55.80-32.76-68.40
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q